Iran Injectable Products Company (DEFRA) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DEFRA
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1404/12/29 | Report to 1403/12/30 | Report to 1402/12/29 | Report to 1401/12/29 |
|---|---|---|---|---|
| P/E TTM | 12.96 | 11.25 | 8.82 | 10.27 |
| P/S TTM | 7.88 | 6.63 | 4.99 | 6.75 |
| P/B | 9.31 | 8.13 | 6.28 | 7.64 |
| Gross margin TTM | 72.7% | 71.0% | 69.0% | 68.8% |
| Net margin TTM | 60.8% | 59.0% | 56.5% | 65.8% |
| ROA TTM | 53.6% | 50.9% | 50.2% | 60.8% |
| ROE TTM | 71.8% | 72.3% | 71.2% | 74.4% |
| Collection period TTM | 154 days | 196 days | 162 days | 115 days |
| Inventory period TTM | 88 days | 110 days | 126 days | 116 days |
| PEG TTM | 0.10 | 0.30 | 0.31 | 0.19 |
| PEGY TTM | 0.10 | 0.27 | 0.23 | 0.16 |